Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Diet/Exercise, Niacin, Fenofibrate for HIV Lipodystrophy
Brief Summary: This study will evaluate the efficacy of diet and exercise (DE), with and without niacin and fenofibrate, in reducing the cardiovascular risk of patients with HIV lipodystrophy or dyslipidemia.


Options:
A: Intervention Type: DRUG; Name: Niacin Extended-Release and simvastatin Tablets; Assigned to Arm(s): N/A
B: Arm Label: 1; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebos | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Diet, Behavioral: Exercise, Other: Placebos | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Behavioral: Diet, Behavioral: Exercise, Drug: Niacin, Other: Placebos | Arm Label: 4; Type: EXPERIMENTAL; Interventions: Behavioral: Diet, Behavioral: Exercise, Drug: Fenofibrate, Other: Placebos | Arm Label: 5; Type: EXPERIMENTAL; Interventions: Behavioral: Diet, Behavioral: Exercise, Drug: Niacin, Drug: Fenofibrate | Intervention Type: BEHAVIORAL; Name: Diet; Assigned to Arm(s): 2, 3, 4, 5 | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): 2, 3, 4, 5 | Intervention Type: DRUG; Name: Niacin; Assigned to Arm(s): 3, 5 | Intervention Type: DRUG; Name: Fenofibrate; Assigned to Arm(s): 4, 5 | Intervention Type: OTHER; Name: Placebos; Assigned to Arm(s): 1, 2, 3, 4
C: Arm Label: Part 1 - Arm 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Comparator: ezetimibe/simvastatin + niacin (ER) | Arm Label: Part 1 -Arm 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Comparator: ezetimibe (+) simvastatin, Drug: Comparator: Placebo to Niacin (ER) | Arm Label: Part 1 - Arm 3; Type: ACTIVE_COMPARATOR; Interventions: Drug: Comparator: Placebo to ezetimibe/simvastatin, Drug: Comparator: niacin (ER) tablet | Arm Label: Part 2 - Arm 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Comparator: ezetimibe/simvastatin and niacin (ER) | Arm Label: Part 2 - Arm 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Comparator: ezetimibe and simvastatin, Drug: Comparator: Placebo to niacin (ER) | Intervention Type: DRUG; Name: Comparator: ezetimibe/simvastatin + niacin (ER); Assigned to Arm(s): Part 1 - Arm 1 | Intervention Type: DRUG; Name: Comparator: Placebo to ezetimibe/simvastatin; Assigned to Arm(s): Part 1 - Arm 3 | Intervention Type: DRUG; Name: Comparator: niacin (ER) tablet; Assigned to Arm(s): Part 1 - Arm 3 | Intervention Type: DRUG; Name: Comparator: ezetimibe (+) simvastatin; Assigned to Arm(s): Part 1 -Arm 2 | Intervention Type: DRUG; Name: Comparator: Placebo to Niacin (ER); Assigned to Arm(s): Part 1 -Arm 2 | Intervention Type: DRUG; Name: Comparator: ezetimibe/simvastatin and niacin (ER); Assigned to Arm(s): Part 2 - Arm 1 | Intervention Type: DRUG; Name: Comparator: ezetimibe and simvastatin; Assigned to Arm(s): Part 2 - Arm 2 | Intervention Type: DRUG; Name: Comparator: Placebo to niacin (ER); Assigned to Arm(s): Part 2 - Arm 2
D: Arm Label: Extended-release niacin; Type: EXPERIMENTAL; Interventions: Drug: extended-release niacin (Niaspan) | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: extended-release niacin (Niaspan) | Intervention Type: DRUG; Name: extended-release niacin (Niaspan); Assigned to Arm(s): Extended-release niacin, Placebo

Answer: B